| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/18/2012 | CN102319418A Buserelin preparation and preparation method thereof |
| 01/18/2012 | CN102319392A Traditional Chinese medicine pill for treating uterine fibroids and preparation method thereof |
| 01/18/2012 | CN102319391A Chinese medicinal soft capsule for treating uterine fibroid and preparation method thereof |
| 01/18/2012 | CN102319379A Formula for treating and preventing cancerous tumors and preparation and production process of Chinese caterpillar fungus tumor rehabilitation oral liquid |
| 01/18/2012 | CN102319364A Manufacturing method of dendrobium candidum wallex lindll pure powder tablets |
| 01/18/2012 | CN102319344A Rhizoma paridis total saponin solid dispersion and preparation method thereof |
| 01/18/2012 | CN102319319A Solanum lyratum extract, and anticancer medicine comprising solanum lyratum extract |
| 01/18/2012 | CN102319310A Chinese herbal medicine with anti-cancer effect |
| 01/18/2012 | CN102319300A Method for extracting total saponins from beesia calthaefolia medicinal material |
| 01/18/2012 | CN102319291A Total phenolic acid extract of broussonetia papyrifera leaves, and application of total phenolic acid extract of broussonetia papyrifera leaves in preparing anti-cancer drugs |
| 01/18/2012 | CN102319290A Medicament for preventing cancer cells from proliferating to lungs after radiation treatment of nasopharyngeal darcinoma |
| 01/18/2012 | CN102319277A Method for preparing fumaria capreolata L. total alkaloid extract |
| 01/18/2012 | CN102319266A krill and/or marine extracts for prevention and/or treatment of cardiovascular diseases, arthritis, skin cancer, diabetes, premenstrual syndrome and transdermal transport |
| 01/18/2012 | CN102319260A Application of cisplatin combined with itraconazole isomer in preparation of medicine used for treating lung cancer |
| 01/18/2012 | CN102319255A Anti-radiation spriulina polysaccharide organic bio-active iodine and application thereof |
| 01/18/2012 | CN102319254A Application of 5-iodo-sterilization nuclide to preparation of anti-tumor medicaments |
| 01/18/2012 | CN102319249A Anti-leukemia small molecular compound targeting mir-150 |
| 01/18/2012 | CN102319248A Liver cancer resisting micro-molecular compound targeted at mir-122 |
| 01/18/2012 | CN102319247A Mir-26a-targeted anti-osteosarcoma small molecular compound |
| 01/18/2012 | CN102319244A Application of 5-benzyl-4-alkyl-2-aryl aminothiazole serving as anti-cervical cancer medicaments |
| 01/18/2012 | CN102319243A Application of compound |
| 01/18/2012 | CN102319242A Application of indazole bi-aryl urea compound serving as protein kinase inhibitor |
| 01/18/2012 | CN102319241A Application of compound in preparing anti-mammary cancer medicament aiming at CCL (CC chemokine ligand) 18 target |
| 01/18/2012 | CN102319239A Application of ainsliaidimer A in preparing nucleolus transcription factor inhibitor medicament |
| 01/18/2012 | CN102319238A Anti-leukemia small molecule compound targeting mir-16 |
| 01/18/2012 | CN102319235A Application of compound |
| 01/18/2012 | CN102319234A Application of curcumin in preparation of thyroid carcinoma therapeutic agent |
| 01/18/2012 | CN102319232A Mir-133-targeted anti-osteosarcoma small molecular compound |
| 01/18/2012 | CN102319230A Implantable 5-fluorouracil sustained and controlled release delivery system and preparation method thereof |
| 01/18/2012 | CN102319222A Decitabine freeze-dried preparation and preparation method thereof |
| 01/18/2012 | CN102319217A Polysaccharide coated magnetic nano-particle and preparation method |
| 01/18/2012 | CN102319214A Lipid microsphere injection containing sodium demethyl cantharidate-phosphatide complex and preparation method thereof |
| 01/18/2012 | CN102319211A Preparation process and application of tryptanthrin injection emulsion |
| 01/18/2012 | CN102319207A 42-(dimethylphosphinate) rapamycin liquid composition |
| 01/18/2012 | CN102114154B Oral traditional Chinese medicine decoction for treating gastric cancer |
| 01/18/2012 | CN102114081B Traditional Chinese medicine for treating breast cancer |
| 01/18/2012 | CN101891834B Polysaccharide sulfate fragment (PSC), preparation method and application thereof |
| 01/18/2012 | CN101863871B Total glycosides of Rhodiola rosea, medical application and preparation method thereof |
| 01/18/2012 | CN101721684B Immunowakeup microsystem as well as preparation method and application thereof |
| 01/18/2012 | CN101712669B Method for separating and purifying luteolin |
| 01/18/2012 | CN101531613B Aminopeptidase N inhibitor bestatin dino ester, synthesis and application thereof |
| 01/18/2012 | CN101524493B Multifunctional Chinese medicine honeyed pill |
| 01/18/2012 | CN101390871B Ginsenoside Rb1 containing impurity ginsenoside Rd |
| 01/18/2012 | CN101239180B Complexes for target killing tumor cell, preparation and application thereof |
| 01/17/2012 | US8097620 Diazaquinolones that inhibit prolyl hydroxylase activity |
| 01/17/2012 | US8097611 Sulfonyl-derivatives as novel or histone deacetylase |
| 01/17/2012 | US8097593 Lipid A and other carbohydrate ligand analogs |
| 01/17/2012 | US8097257 MAGE3 polypeptides |
| 01/17/2012 | US8097254 Specific binding molecules for scintigraphy, conjugates containing them and therapeutic method for treatment of angiogenesis |
| 01/17/2012 | US8097252 Methods and compositions for administering therapeutic and diagnostic agents |
| 01/17/2012 | US8097244 Human prostate cell lines in cancer treatment |
| 01/17/2012 | US8097238 Cell targeting conjugates |
| 01/17/2012 | US8097236 The invention relates to an internal therapeutic product comprising: (i) an anti-cancer component selected from one or both of: a radionucleotide, a cytotoxic drug; and (ii) a silicon component selected from one or more of: resorbable |
| 01/17/2012 | US8096419 Compound |
| 01/17/2012 | CA2657594C Pyrrolotriazine kinase inhibitors |
| 01/17/2012 | CA2611032C 2-indolyl imidazo[4,5-d]phenanthroline derivatives and their use in the treatment of cancer |
| 01/17/2012 | CA2517390C Chroman-derived anti-androgens for treatment of androgen-mediated disorders |
| 01/17/2012 | CA2485852C Agent for binding a plurality of c-reactive protein and their use in the treatment and prevention of tissue damage |
| 01/17/2012 | CA2484640C Vitamin-mitomycin conjugates |
| 01/17/2012 | CA2484269C Compounds and method for coating surfaces in a haemocompatible manner |
| 01/17/2012 | CA2473986C Indazole compounds useful as protein kinase inhibitors |
| 01/17/2012 | CA2451353C Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer |
| 01/17/2012 | CA2451244C Purine derivatives as a2b adenosine receptor antagonists |
| 01/17/2012 | CA2441958C Il-28 polypeptides and polynucleotids |
| 01/17/2012 | CA2148712C Peripheralization of hematopoietic stem cells |
| 01/12/2012 | WO2012006589A2 Methods and compositions for identification, assessment and treatment of cancers associated with hedgehog signaling |
| 01/12/2012 | WO2012006584A2 Therapeutic regimens for hedgehog-associated cancers |
| 01/12/2012 | WO2012006563A2 Novel daidzein analogs as treatment for cancer |
| 01/12/2012 | WO2012006552A1 Combinations of kinase inhibitors for the treatment of cancer |
| 01/12/2012 | WO2012006550A2 Methods and compositions for treatment of lipogenic virus related conditions |
| 01/12/2012 | WO2012006506A1 Metabolic gene, enzyme, and flux targets for cancer therapy |
| 01/12/2012 | WO2012006500A2 Monoclonal antibodies against hepatitis c virus core protein |
| 01/12/2012 | WO2012006490A2 Dual variable domain immunoglobulins and uses thereof |
| 01/12/2012 | WO2012006275A2 Treating non-hematopoietic cancer with interleukin 6 |
| 01/12/2012 | WO2012006145A2 Com positions and methods for retargeting virus constructs |
| 01/12/2012 | WO2012006032A2 Treatment of blood cancer |
| 01/12/2012 | WO2012005581A1 Xanthanodien for the treatment of cancer |
| 01/12/2012 | WO2012005572A1 Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway |
| 01/12/2012 | WO2012005550A2 Pharmaceutical composition for treating gallbladder carcinoma, and method for inhibiting growth and metastasis of gallbladder carcinoma and treating gallbladder carcinoma, using same |
| 01/12/2012 | WO2012005299A1 Ros tyrosine kinase inhibitor |
| 01/12/2012 | WO2012005229A1 N-hydroxyformamide derivative and pharmaceutical containing same |
| 01/12/2012 | WO2012005227A1 Tetrahydrocarboline derivative |
| 01/12/2012 | WO2012005161A1 Cancer peptide vaccine |
| 01/12/2012 | WO2012004917A1 Neurite outgrowth agent |
| 01/12/2012 | WO2012004875A1 Novel substance separated from orchidaceous plant, and extract, antioxidant, antibacterial agent, anticancer agent and antiinflammatory agent containing same |
| 01/12/2012 | WO2012004732A1 Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof |
| 01/12/2012 | WO2012004731A1 Indolizine derivatives, process for the preparation thereof and therapeutic use thereof |
| 01/12/2012 | WO2012004653A1 Method for inhibition of nf-kb gene expression |
| 01/12/2012 | WO2012004410A1 B7-h3 antagonists and taxanes |
| 01/12/2012 | WO2012004385A1 New all trans platinum (iv) complexes, their preparation and their use as antitumor agents |
| 01/12/2012 | WO2012004330A1 Nos-inhibitor l-nil for use in chronic pulmonary diseases |
| 01/12/2012 | WO2012004009A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | WO2012004007A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | WO2012004006A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | WO2012004005A1 Conjugates comprising hydroxyalkyl starch and a cytotoxic agent and process for their preparation |
| 01/12/2012 | WO2012003995A1 Lipid-conjugated antibodies |
| 01/12/2012 | WO2012003956A1 Cancer therapy using cldn6 target-directed antibodies in vivo |
| 01/12/2012 | WO2012003912A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 01/12/2012 | WO2012003814A1 Vaccine compositions based on sticholysin encapsulated in liposomes |
| 01/12/2012 | WO2012003810A1 Regulatory factor of foxp3 and regulatory t cells and use thereof |